Overview

Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Study the endometrial predecidualization by using subcutaneous progesterone 25 mg/day versus intramuscular progesterone 50 mg/day, to determine whether there are differences in the endometrial transformation and endometrial receptivity.
Phase:
Phase 4
Details
Lead Sponsor:
IVI Barcelona
Treatments:
Progesterone